tiprankstipranks
Trending News
More News >
Denali Therapeutics (DE:4DN)
FRANKFURT:4DN
Germany Market

Denali Therapeutics (4DN) Income Statement

Compare
7 Followers

Denali Therapeutics Income Statement

Last quarter (Q3 2025), Denali Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Denali Therapeutics's net income was $-126.90M. See Denali Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 330.53M$ 108.46M$ 48.66M$ 335.66M
Gross Profit
$ 0.00$ 330.53M$ 108.46M$ 48.66M$ 335.66M
Operating Expenses
$ 487.34M$ 527.23M$ 449.21M$ 344.41M$ 272.94M
Depreciation and Amortization
$ 8.99M$ 16.73M$ 10.38M$ 8.59M$ 8.53M
EBITDA
$ -492.89M$ -179.97M$ -330.36M$ -287.16M$ 71.25M
Operating Income
$ -487.34M$ -196.70M$ -340.74M$ -295.75M$ 62.72M
Other Income/Expenses
$ 64.64M$ 51.51M$ 14.77M$ 4.59M$ 9.24M
Pretax Income
$ -422.70M$ -145.19M$ -325.97M$ -291.16M$ 71.96M
Net Income
$ -422.77M$ -145.22M$ -325.99M$ -290.58M$ 71.14M
Per Share Metrics
Basic EPS
$ -2.57$ -1.06$ -2.60$ -2.39$ 0.65
Diluted EPS
$ -2.57$ -1.06$ -2.60$ -2.39$ 0.63
Weighted Average Shares Outstanding
164.47M 137.37M 125.53M 121.52M 108.97M
Weighted Average Shares Outstanding (Diluted)
164.47M 137.37M 125.53M 121.52M 112.70M
Currency in USD

Denali Therapeutics Earnings and Revenue History